| Pharmaceutical active ingredients: |
| Bromhexine HydrochlorideFenoterol Hydrobromide |
| Available forms, composition and doses of Berosolvon: |
| Solution; Oral; Bromhexine Hydrochloride; Fenoterol Hydrobromide |
| Berosolvon medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03AK03 - Fenoterol and other drugs for obstructive airway diseases |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer Ingelheim |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Bisolvonat | Bromhexine Hydrochloride; Erythromycin Ethylsuccinate | Boehringer Ingelheim |
| Synergomycin | Bromhexine Hydrochloride; Erythromycin Ethylsuccinate | Abbott |
| Alibron | Bromhexine Hydrochloride; Erythromycin Propionate | Boehringer Ingelheim |
| Eriwest | Bromhexine Hydrochloride; Erythromycin Stearate | Bruluagsa |
| Pantobron | Bromhexine Hydrochloride; Erythromycin; Erythromycin Ethylsuccinate | Abbott |
| Berotec Solvens | Bromhexine Hydrochloride; Fenoterol Hydrobromide | Boehringer Ingelheim |
| Solvelin | Bromhexine Hydrochloride; Feprazone | Istituto de Angeli |
| Mitibron | Bromhexine Hydrochloride; Fibracillin; Guaifenesin | Sanofi-Aventis |
| Broncho-Noleptan | Bromhexine Hydrochloride; Fominoben Hydrochloride | Boehringer Ingelheim |
| Bronco Aseptilex Fuerte | Bromhexine Hydrochloride; Guaiacol Cinnamate; Sulfamethoxazole; Trimethoprim | Chiesi |